The Applicability of Comorbidity Indices in Predicting Chemo toxicity in Non-Small Cell Lung Cancer

被引：1

作者：

Edahyr, Boshra ^{[1
]}

Lind, Michael ^{[2
]}

Karsera, Louise ^{[1
]}

Mafi, Reza ^{[1
]}

Wallace, Karen ^{[1
]}

Howell, Gareth ^{[1
]}

Hemmingway, Carl ^{[1
]}

Stubbs, Karen ^{[1
]}

机构：

[1] Univ Hull, Acad Oncol, Cottingham, England

[2] Univ Hull, Hull York Med Sch, Cottingham, England

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

Co-morbidity; toxicity; predictive;

D O I：

10.1016/j.jtho.2016.11.2038

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PUB068

引用

页码：S1487 / S1488

页数：2

共 50 条

[21] Predictors of Survival in Patients With Non-Small Cell Lung Cancer [J].

Luo, Juhua ;

Chen, Yea-Jyh ;

Narsavage, Georgia L. ;

Ducatman, Alan .

ONCOLOGY NURSING FORUM, 2012, 39 (06) :609-616

[22] Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer [J].

Thakur, Manish K. ;

Gadgeel, Shirish M. .

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (05) :760-770

[23] Comorbidity as a Prognostic Factor in Elderly Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy [J].

Sazdanic-Velikic, Danica ;

Tepavac, Aleksandar ;

Lalic, Nensi ;

Stojkovic, Ivana ;

Secen, Nevena .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S914-S914

[24] The influence of comorbidity and other risk factors on early postoperative complications after lobectomy for non-small cell lung cancer [J].

Kowalewski, Janusz ;

Sedlak, Anna .

KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2009, 6 (04) :359-363

[25] Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-) radiotherapy using IMRT or VMAT [J].

Wijsman, Robin ;

Dankers, Frank ;

Troost, Esther G. C. ;

Hoffmann, Aswin L. ;

van der Heijden, Erik H. F. M. ;

de Geus-Oei, Lioe-Fee ;

Bussink, Johan .

RADIOTHERAPY AND ONCOLOGY, 2017, 122 (02) :295-299

[26] Early High-Grade Thoracic Toxicity After Palliative Radiotherapy for Non-Small Cell Lung Cancer [J].

Nieder, Carsten ;

Imingen, Kristian .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)

[27] Association of Crizotinib Toxicity with Pharmacokinetics and Pharmacogenomics in Non-Small Cell Lung Cancer Harboring ALK Fusion Gene [J].

Tambo, Yuichi ;

Yamada, Kazuhiko ;

Umemura, Shigeki ;

Saeki, Sho ;

Nakamura, Yukiko ;

Shukuya, Takehito ;

Urata, Yoshiko ;

Okuma, Yusuke ;

Fukui, Tomoya ;

Kogure, Yoshihito ;

Daga, Haruko ;

Hasegawa, Yoshinori ;

Tsubata, Yukari ;

Yoshida, Tatsuya ;

Oizumi, Satoshi ;

Tamura, Yosuke ;

Mizugaki, Hidenori ;

Fujiwara, Yutaka ;

Hamada, Akinobu ;

Ohe, Yuichiro .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S378-S378

[28] Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation [J].

Simon, Tracey G. ;

Beland, Michael D. ;

Machan, Jason T. ;

DiPetrillo, Thomas ;

Dupuy, Damian E. .

EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (12) :4167-4172

[29] Effect of Comorbidity on Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD1 Immunotherapy [J].

Zeng, Xianghua ;

Zhu, Shicong ;

Xu, Cheng ;

Wang, Zhongyu ;

Su, Xingxing ;

Zeng, Dong ;

Long, Haixia ;

Zhu, Bo .

MEDICAL SCIENCE MONITOR, 2020, 26

[30] The Prognostic Significance of Comorbidity and Relation of Comorbidity with the Other Prognostic Factors in Patients with Non Small Cell Lung Cancer [J].

Ozgun, M. Alpaslan ;

Karagoz, Buelent ;

Bilgi, Oguz ;

Kandemir, E. Goekhan ;

Turken, Orhan .

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2009, 19 (02) :63-68

← 1 2 3 4 5 →